Cargando…
Variation in human cancer cell external phosphatidylserine is regulated by flippase activity and intracellular calcium
Viable cancer cells expose elevated levels of phosphatidylserine (PS) on the exoplasmic face of the plasma membrane. However, the mechanisms leading to elevated PS exposure in viable cancer cells have not been defined. We previously showed that externalized PS may be used to monitor, target and kill...
Autores principales: | Vallabhapurapu, Subrahmanya D., Blanco, Víctor M., Sulaiman, Mahaboob K., Vallabhapurapu, Swarajya Lakshmi, Chu, Zhengtao, Franco, Robert S., Qi, Xiaoyang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4741459/ https://www.ncbi.nlm.nih.gov/pubmed/26462157 |
Ejemplares similares
-
Enhanced phosphatidylserine-selective cancer therapy with irradiation and SapC-DOPS nanovesicles
por: Davis, Harold W., et al.
Publicado: (2019) -
Phosphatidylserine-selective targeting and anticancer effects of SapC-DOPS nanovesicles on brain tumors
por: Blanco, Víctor M., et al.
Publicado: (2014) -
SapC-DOPS nanovesicles induce Smac- and Bax-dependent apoptosis through mitochondrial activation in neuroblastomas
por: Sulaiman, Mahaboob K, et al.
Publicado: (2015) -
Targeting of elevated cell surface phosphatidylserine with saposin C-dioleoylphosphatidylserine nanodrug as individual or combination therapy for pancreatic cancer
por: Davis, Harold W, et al.
Publicado: (2021) -
Biotherapy of Brain Tumors with Phosphatidylserine-Targeted Radioiodinated SapC-DOPS Nanovesicles
por: Davis, Harold W., et al.
Publicado: (2020)